Yes, this is the problem and what I really wanted to underline also, not just in presentations, but everywhere that we are talking about this topic, because a lot of developed countries have these possibilities for families that they want to be tested. What about the countries like mine, for example? I have 11 cases in my family that have breast cancer. And for example, let us say Angelina Jolie, the case of Angelina Jolie that brings a lot of attention to BRCA genetic testing...
Yes, this is the problem and what I really wanted to underline also, not just in presentations, but everywhere that we are talking about this topic, because a lot of developed countries have these possibilities for families that they want to be tested. What about the countries like mine, for example? I have 11 cases in my family that have breast cancer. And for example, let us say Angelina Jolie, the case of Angelina Jolie that brings a lot of attention to BRCA genetic testing. And sometimes you don’t need these headlines to know what is wrong with your genes. And of course, in these countries like mine, it is very important to have a clear strategy and maybe to work more on an international level and how to include other countries as well. Of course, it’s our responsibility for each country to work with each national policymaker, but we need to push this topic more. And this is what we also said and also mentioned, and also in my presentation, that despite everything that we read and it’s already been published, it also depends on our national guidelines.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
